ALHC

SEC source: 0000899243-21-015447 · doc4.xml · derivative · entry 3

Foster Michael Curtis · CIK 0001850411 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 346,296

Underlying: Common Stock · 346,296 shares

Expires 2031-03-25

F3 · kind: Represents 346,296 options to purchase Common Stock of the Company at the initial public offering price. The securities covered by such transaction were previously included on Mr. Foster's Form 3.

F4 · derivative.exercise_date: Vest 25% on the first four anniversaries of the initial vesting date.

SEC source: 0000899243-21-015447 · doc4.xml · nonDerivative · entry 1

Foster Michael Curtis · CIK 0001850411 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,132,692

F1 · kind: Represents 27,500 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of Alignment Healthcare, Inc. (the "Company"), that will vest 25% on the first four anniversaries of the initial vesting date. The securities covered by such transaction were previously included on Mr. Foster's Form 3.

SEC source: 0000899243-21-015446 · doc4.xml · derivative · entry 6

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 572,040

Underlying: Common Stock · 572,040 shares

Expires 2031-03-25

F9 · kind: Represents 572,042 options to purchase Common Stock of the Company at the initial public offering price. The securities covered by such transaction were previously included on Mr. Freeman's Form 3.

F8 · derivative.exercise_date: Vest 25% on the first four anniversaries of the initial vesting date.

F5 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary.

SEC source: 0000899243-21-015446 · doc4.xml · derivative · entry 5

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,680

Underlying: Common Stock · 190,680 shares

Expires 2031-03-25

F7 · kind: Represents 190,680 options to purchase Common Stock of the Company at the initial public offering price. The securities covered by such transaction were previously included on Mr. Freeman's Form 3.

F8 · derivative.exercise_date: Vest 25% on the first four anniversaries of the initial vesting date.

SEC source: 0000899243-21-015446 · doc4.xml · nonDerivative · entry 3

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 924,564

F4 · kind: Represents 45,427 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on the first four anniversaries of the initial vesting date. The securities covered by such transaction were previously included on Mr. Freeman's Form 3.

F5 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary.

SEC source: 0000899243-21-015446 · doc4.xml · nonDerivative · entry 2

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 238,489

F3 · kind: Represents 15,142 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on the first four anniversaries of the initial vesting date. The securities covered by such transaction were previously included on Mr. Freeman's Form 3.

SEC source: 0000899243-21-015446 · doc4.xml · nonDerivative · entry 1

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 223,347

F1 · kind: Represents 38,060 shares of Common Stock of Alignment Healthcare, Inc. (the "Company") and 19,030 restricted shares of Common Stock of the Company that will vest upon a change of control of the Company or otherwise (A) if received in exchange for pre-IPO (as defined below) transaction-based stock appreciation rights, on the later of (x) the four-year anniversary of the initial vesting date, or (y) 50% on the first anniversary of Company's initial public offering (the "IPO") and 50% on the second anniversary of the IPO, in each case, subject to Ms. Freeman's continued employment or service on each such vesting date and (B) if received in exchange for pre-IPO service-based stock appreciation rights, and (Continued in Footnote 2)

F2 · kind: (Continued From Footnote 1) (B) if received in exchange for pre-IPO service-based stock appreciation rights, according to the pre-IPO vesting schedule applicable to Mr. Freeman disclosed in the "Executive Compensation - Outstanding Equity Awards at Fiscal Year End" section of the Company's registration statement on Form S-1. The securities covered by such transaction were previously included on Mr. Freeman's Form 3.

SEC source: 0000899243-21-015437 · doc4.xml · nonDerivative · entry 1

McClellan Mark B. · CIK 0001567006 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 296,422

F1 · kind: Represents 33,333 shares of restricted Common Stock that will vest in equal annual installments on each of the first three anniversaries of the initial public offering of Alignment Healthcare, Inc. (the "Company") unless Mr. McClellan is removed for cause or resigns prior to such dates. The securities covered by such transaction were previously included on Mr. McClellan's Form 3.

SEC source: 0000899243-21-015550 · doc4a.xml · nonDerivative · entry 2

KOSECOFF JACQUELINE B · CIK 0001209524 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 182,983

F2 · kind: Represents 33,333shares of restricted Common Stock of the Company that will vest in equal annual installments on each of the first three anniversaries of the IPO unless Ms. Kosecoff is removed for cause or resigns prior to such dates. The securities covered by such transaction were previously included on Ms. Kosecoff's Form 3.

SEC source: 0000899243-21-015550 · doc4a.xml · nonDerivative · entry 1

KOSECOFF JACQUELINE B · CIK 0001209524 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,650

F1 · kind: Represents 11,418 shares of Common Stock of Alignment Healthcare, Inc. (the "Company") and 5,709 restricted shares of Common Stock of the Company that will vest upon a change of control of the Company or otherwise (A) if received in exchange for pre-IPO (as defined below) transaction-based stock appreciation rights, on the later of (x) the four-year anniversary of the initial vesting date, or (y) 50% on the first anniversary of Company's initial public offering (the "IPO") and 50% on the second anniversary of the IPO, in each case, subject to Ms. Kosecoff's continued employment or service on each such vesting date and (B) if received in exchange for pre-IPO service-based stock appreciation rights, according to the pre-IPO vesting schedule of the pre-IPO service-based stock appreciation rights. The securities covered by such transaction were previously included on Ms. Kosecoff's Form 3.

SEC source: 0000950142-21-001593 · es210151513_4a-margolis.xml · nonDerivative · entry 1

MARGOLIS JEFFREY H · CIK 0001105688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 472,587

F1 · kind: Represents 33,333 shares of restricted Common Stock of Alignment Healthcare, Inc. (the "Company") that will vest in equal annual installments on each of the first three anniversaries of the Company's initial public offering unless Mr. Margolis is removed for cause or resigns prior to such dates. The securities covered by such transaction were previously included on Mr. Margolis's Form 3.

SEC source: 0000950142-21-001592 · es210148620_4a-freeman.xml · derivative · entry 4

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 762,720

Underlying: Common Stock · 762,720 shares

Expires 2031-03-25

F6 · kind: Represents 762,720 options to purchase Common Stock of the Company at the initial public offering price. The securities covered by such transaction were previously included on Mr. Freeman's Form 3.

F7 · derivative.exercise_date: Vest 25% on the first four anniversaries of the initial vesting date.

SEC source: 0000950142-21-001592 · es210148620_4a-freeman.xml · nonDerivative · entry 2

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 283,916

F3 · kind: Represents 60,569 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on the first four anniversaries of the initial vesting date. The securities covered by such transaction were previously included on Mr. Freeman's Form 3.

SEC source: 0000950142-21-001592 · es210148620_4a-freeman.xml · nonDerivative · entry 1

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 223,347

F1 · kind: Represents 38,060 shares of Common Stock of Alignment Healthcare, Inc. (the "Company") and 19,030 restricted shares of Common Stock of the Company that will vest upon a change of control of the Company or otherwise (A) if received in exchange for pre-IPO (as defined below) transaction-based stock appreciation rights, on the later of (x) the four-year anniversary of the initial vesting date, or (y) 50% on the first anniversary of Company's initial public offering (the "IPO") and 50% on the second anniversary of the IPO, in each case, subject to Ms. Freeman's continued employment or service on each such vesting date and (B) if received in exchange for pre-IPO service-based stock appreciation rights, and (Continued in Footnote 2)

F2 · kind: (Continued From Footnote 1) (B) if received in exchange for pre-IPO service-based stock appreciation rights, according to the pre-IPO vesting schedule applicable to Mr. Freeman disclosed in the "Executive Compensation - Outstanding Equity Awards at Fiscal Year End" section of the Company's registration statement on Form S-1. The securities covered by such transaction were previously included on Mr. Freeman's Form 3.